Parallel Session 4 :Hot Topics on the Treatment of Ovarian Cancer
Date:2024-05-26
Site:Room 308
NO. | Beijing Time (UTC+8) | Local Time | Presentation Topic | Speaker | Affiliation / Organization |
---|---|---|---|---|---|
1 | 08:00-08:20 | 08:00 -08:20 |
Exploratory Research on Reversing PARP Inhibitor Resistance |
Qinglei Gao | Tongji Hospital,Tongji Medical College of HUST |
2 | 08:20-08:40 | 08:20 -08:40 |
Biomarker-Based Targeted Therapy |
Xin Lu | Obstetrics & Gynecology Hospital Of Fudan University |
3 | 08:40-09:00 | 08:40 -09:00 |
Advances in Maintenance Therapy for Platinum-Sensitive Recurrent Ovarian Cancer |
Hong Zheng | Beijing Cancer Hospital |
4 | 09:00-09:20 | 09:00 -09:20 |
Difficulties and Breakthroughs in Immunotherapy for Ovarian Cancer |
Yuanguang Meng | Chinese PLA General Hospital |
5 | 09:20-09:40 | 09:20 -09:40 |
Latest Evidence of Hyperthermic Intraperitoneal Chemotherapy in the Treatment of Ovarian Cancer |
Zhongqiu Lin | Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University |
NO. | Beijing Time (UTC+8) | Local Time | Presentation Topic | Speaker | Affiliation / Organization |
---|---|---|---|---|---|
1 | 09:40-10:00 | 09:40 -10:00 |
Advances in Basic and Clinical Research on Ovarian Clear Cell Carcinoma |
Wen Di | Renji Hospital Affiliated to Shanghai Jiaotong University School of Medicine |
2 | 10:00-10:20 | 10:00 -10:20 |
Application of Endoscopic Techniques in the Diagnosis and Treatment of Gestational Trophoblastic Neoplasia |
Yang Xiang | Peking Union Medical College Hospital |
3 | 10:20-10:40 | 10:20 -10:40 |
Laparoscopic surgery in the treatment of recurrent ovarian cancer |
Shuzhong Yao | The First Affiliated Hospital,Sun Yat-sen University |
4 | 10:40-10:55 | 10:40 -10:55 |
Industrial session-Interpretation of data of anlotinib in the field of onmatoma |
Guo Zhang | Peking University People’s Hospital |
Parallel Session 8:Chemotherapy and Immunotherapy for Gynecologic Malignancies
Date:2024-05-26
Site:Room 308
NO. | Beijing Time (UTC+8) | Local Time | Presentation Topic | Speaker | Affiliation / Organization |
---|---|---|---|---|---|
1 | 13:30-13:50 | 13:30 -13:50 |
Expert Consensus on Genetic Counseling for Gynecologic Tumors |
Congjian Xu | Obstetrics & Gynecology Hospital Of Fudan University |
2 | 13:50-14:10 | 13:50 -14:10 |
Clinical Practice Guidelines for the Application of Antiangiogenic Agents in Gynecological Tumors |
Bin Li | Cancer Hospital Chinese Academy of Medical Sciences |
3 | 14:10-14:30 | 14:10 -14:30 |
Application of Antibody-Drug Conjugates (ADCs) in Gynecological Tumors |
Ruixia Guo | First affiliated hospital of zhengzhou university |
4 | 14:30-14:45 | 14:30 -14:45 |
Industrial session-Efficacy and Safety of Paclitaxel Liposome Versus Paclitaxel In Combination With Carboplatin In the First-line Chemotherapy For Ovarian Cancer |
Qinglei Gao | Tongji Hospital,Tongji Medical College of HUST |
NO. | Beijing Time (UTC+8) | Local Time | Presentation Topic | Speaker | Affiliation / Organization |
---|---|---|---|---|---|
1 | 14:45-15:05 | 14:45 -15:05 |
Advances in Tumor-Targeted therapy and Immunotherapy for Special Types of Endometrial Cancer |
Xipeng Wang | Xinhua Hospital Affiliated To Shanghai Jiao Tong University School of Medicine |
2 | 15:05-15:25 | 15:05 -15:25 |
Gynecological Tumor Immunotherapy: Side Effects Prevention and Management |
Jie Jiang | Qilu Hospital Of Shandong University |
3 | 15:25-15:45 | 15:25 -15:45 |
Consensus of Experts on Liver Metastasis of Ovarian Cancer |
Xiaoping Li | Peking University Peoples Hospital |
4 | 15:45-16:05 | 15:45 -16:05 |
Exploration of Anti-HER2 Therapy in Gynecological Tumors |
Yi Li | Peking University People's Hospital |
5 | 16:05-16:25 | 16:05 -16:25 |
Treatment of Gynecological Tumors with Arsenic Trioxide based Chemotherapy |
Yingchao Yang | Peking University People's Hospital |